Maprotiline Hcl


Maprotiline Hcl

Drug - Maprotiline Hcl
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Maprotiline Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 75MG
The potency of the active ingredient(s), Maprotiline Hydrochloride. May repeat for multiple part products.

Applicant - AM THERAP
The firm name holding legal responsibility for Maprotiline Hcl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 072131
The FDA assigned number to Maprotiline Hcl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Maprotiline Hcl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 14, 1988
The date Maprotiline Hcl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Maprotiline Hcl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Maprotiline Hcl is in. Format is RX, OTC, DISCN.

Applicant Full Name - American Therapeutics Inc
The full name of the firm holding legal responsibility for the new application of Maprotiline Hcl.

Maprotiline Hcl